228 related articles for article (PubMed ID: 15800124)
1. Relative glomerular hyperfiltration in primary aldosteronism.
Ribstein J; Du Cailar G; Fesler P; Mimran A
J Am Soc Nephrol; 2005 May; 16(5):1320-5. PubMed ID: 15800124
[TBL] [Abstract][Full Text] [Related]
2. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas.
Rossi E; Sani C; Perazzoli F; Casoli MC; Negro A; Dotti C
Am J Hypertens; 1995 Sep; 8(9):884-93. PubMed ID: 8541003
[TBL] [Abstract][Full Text] [Related]
3. Association of kidney function with residual hypertension after treatment of aldosterone-producing adenoma.
; Wu VC; Chueh SC; Chang HW; Lin LY; Liu KL; Lin YH; Ho YL; Lin WC; Wang SM; Huang KH; Hung KY; Kao TW; Lin SL; Yen RF; Chen YM; Hsieh BS; Wu KD
Am J Kidney Dis; 2009 Oct; 54(4):665-73. PubMed ID: 19628318
[TBL] [Abstract][Full Text] [Related]
4. Kidney impairment in primary aldosteronism.
Wu VC; Yang SY; Lin JW; Cheng BW; Kuo CC; Tsai CT; Chu TS; Huang KH; Wang SM; Lin YH; Chiang CK; Chang HW; Lin CY; Lin LY; Chiu JS; Hu FC; Chueh SC; Ho YL; Liu KL; Lin SL; Yen RF; Wu KD;
Clin Chim Acta; 2011 Jul; 412(15-16):1319-25. PubMed ID: 21345337
[TBL] [Abstract][Full Text] [Related]
5. Primary aldosteronism: changes in cystatin C-based kidney filtration, proteinuria, and renal duplex indices with treatment.
Wu VC; Kuo CC; Wang SM; Liu KL; Huang KH; Lin YH; Chu TS; Chang HW; Lin CY; Tsai CT; Lin LY; Chueh SC; Kao TW; Chen YM; Chiang WC; Tsai TJ; Ho YL; Lin SL; Wang WJ; Wu KD;
J Hypertens; 2011 Sep; 29(9):1778-86. PubMed ID: 21738054
[TBL] [Abstract][Full Text] [Related]
6. Marked association between obesity and glomerular hyperfiltration: a cross-sectional study in an African population.
Wuerzner G; Pruijm M; Maillard M; Bovet P; Renaud C; Burnier M; Bochud M
Am J Kidney Dis; 2010 Aug; 56(2):303-12. PubMed ID: 20538392
[TBL] [Abstract][Full Text] [Related]
7. Effect of Eplerenone on the Glomerular Filtration Rate (GFR) in Primary Aldosteronism: Sequential Changes in the GFR During Preoperative Eplerenone Treatment to Subsequent Adrenalectomy.
Nakano Y; Yoshimoto T; Fukuda T; Murakami M; Bouchi R; Minami I; Hashimoto K; Fujii Y; Kihara K; Ogawa Y
Intern Med; 2018 Sep; 57(17):2459-2466. PubMed ID: 29709927
[TBL] [Abstract][Full Text] [Related]
8. Spironolactone in type 2 diabetic nephropathy: Effects on proteinuria, blood pressure and renal function.
van den Meiracker AH; Baggen RG; Pauli S; Lindemans A; Vulto AG; Poldermans D; Boomsma F
J Hypertens; 2006 Nov; 24(11):2285-92. PubMed ID: 17053552
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study.
Giacchetti G; Ronconi V; Turchi F; Agostinelli L; Mantero F; Rilli S; Boscaro M
J Hypertens; 2007 Jan; 25(1):177-86. PubMed ID: 17143190
[TBL] [Abstract][Full Text] [Related]
10. Relationships of plasma renin levels with renal function in patients with primary aldosteronism.
Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
Clin J Am Soc Nephrol; 2007 Jul; 2(4):722-31. PubMed ID: 17699488
[TBL] [Abstract][Full Text] [Related]
11. Ventricular repolarization before and after treatment in patients with secondary hypertension due to renal-artery stenosis and primary aldosteronism.
Maule S; Bertello C; Rabbia F; Milan A; Mulatero P; Milazzo V; Papotti G; Veglio F
Hypertens Res; 2011 Oct; 34(10):1078-81. PubMed ID: 21677661
[TBL] [Abstract][Full Text] [Related]
12. Urinary aldosterone-to-active-renin ratio: a useful tool for predicting resolution of hypertension after adrenalectomy in patients with aldosterone-producing adenomas.
Mourad JJ; Girerd X; Milliez P; Lopez-Sublet M; Lejeune S; Safar ME
Am J Hypertens; 2008 Jul; 21(7):742-7. PubMed ID: 18443567
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular outcomes in patients with primary aldosteronism after treatment.
Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
Arch Intern Med; 2008 Jan; 168(1):80-5. PubMed ID: 18195199
[TBL] [Abstract][Full Text] [Related]
14. Renal functional reserve and nitric oxide in patients with compensated liver cirrhosis.
Woitas RP; Heller J; Stoffel-Wagner B; Spengler U; Sauerbruch T
Hepatology; 1997 Oct; 26(4):858-64. PubMed ID: 9328305
[TBL] [Abstract][Full Text] [Related]
15. Increased arterial wall stiffness in primary aldosteronism in comparison with essential hypertension.
Strauch B; Petrák O; Wichterle D; Zelinka T; Holaj R; Widimský J
Am J Hypertens; 2006 Sep; 19(9):909-14. PubMed ID: 16942932
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure outcome of adrenalectomy in patients with primary hyperaldosteronism with or without unilateral adenoma.
Letavernier E; Peyrard S; Amar L; Zinzindohoué F; Fiquet B; Plouin PF
J Hypertens; 2008 Sep; 26(9):1816-23. PubMed ID: 18698217
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism.
Pang TC; Bambach C; Monaghan JC; Sidhu SB; Bune A; Delbridge LW; Sywak MS
ANZ J Surg; 2007 Sep; 77(9):768-73. PubMed ID: 17685956
[TBL] [Abstract][Full Text] [Related]
18. Adrenalectomy improves arterial stiffness in primary aldosteronism.
Strauch B; Petrák O; Zelinka T; Wichterle D; Holaj R; Kasalický M; Safarík L; Rosa J; Widimský J
Am J Hypertens; 2008 Oct; 21(10):1086-92. PubMed ID: 18654122
[TBL] [Abstract][Full Text] [Related]
19. Intrarenal hemodynamics in primary aldosteronism before and after treatment.
Sechi LA; Di Fabio A; Bazzocchi M; Uzzau A; Catena C
J Clin Endocrinol Metab; 2009 Apr; 94(4):1191-7. PubMed ID: 19141581
[TBL] [Abstract][Full Text] [Related]
20. Albuminuria in untreated patients with primary aldosteronism or essential hypertension.
Halimi JM; Mimran A
J Hypertens; 1995 Dec; 13(12 Pt 2):1801-2. PubMed ID: 8903655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
